- Home
- CLDX vs WLFC Comparison
CLDX vs WLFC Comparison
Compare CLDX & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- WLFC
- Stock Information
- Founded
- CLDX 1983
- WLFC 1985
- Country
- CLDX United States
- WLFC United States
- Employees
- CLDX N/A
- WLFC N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- WLFC Industrial Specialties
- Sector
- CLDX Health Care
- WLFC Consumer Discretionary
- Exchange
- CLDX Nasdaq
- WLFC Nasdaq
- Market Cap
- CLDX 1.7B
- WLFC 1.1B
- IPO Year
- CLDX 2008
- WLFC 1996
- Fundamental
- Price
- CLDX $20.14
- WLFC $166.27
- Analyst Decision
- CLDX Buy
- WLFC
- Analyst Count
- CLDX 7
- WLFC 0
- Target Price
- CLDX $55.67
- WLFC N/A
- AVG Volume (30 Days)
- CLDX 714.4K
- WLFC 44.3K
- Earning Date
- CLDX 05-05-2025
- WLFC 03-10-2025
- Dividend Yield
- CLDX N/A
- WLFC 0.60%
- EPS Growth
- CLDX N/A
- WLFC 146.23
- EPS
- CLDX N/A
- WLFC 15.34
- Revenue
- CLDX $7,020,000.00
- WLFC $557,540,000.00
- Revenue This Year
- CLDX N/A
- WLFC $1.70
- Revenue Next Year
- CLDX $27.01
- WLFC $13.55
- P/E Ratio
- CLDX N/A
- WLFC $10.84
- Revenue Growth
- CLDX 1.99
- WLFC 36.04
- 52 Week Low
- CLDX $18.61
- WLFC $46.70
- 52 Week High
- CLDX $47.00
- WLFC $235.43
- Technical
- Relative Strength Index (RSI)
- CLDX 41.83
- WLFC 37.17
- Support Level
- CLDX $18.95
- WLFC $146.05
- Resistance Level
- CLDX $21.85
- WLFC $183.23
- Average True Range (ATR)
- CLDX 1.39
- WLFC 11.09
- MACD
- CLDX 0.08
- WLFC -3.14
- Stochastic Oscillator
- CLDX 38.64
- WLFC 31.13
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About WLFC Willis Lease Finance Corporation
Willis Lease Finance Corp with its subsidiaries is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments namely Leasing and Related Operations which involves acquiring and leasing, pursuant to operating leases, commercial aircraft, aircraft engines and other aircraft equipment and the selective purchase and resale of commercial aircraft engines and other aircraft equipment and other related businesses and Spare Parts Sales segment involves the purchase and resale of after-market engine parts, whole engines, engine modules and portable aircraft components. The company generates the majority of its revenue from leasing and related operations.